{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:22:46Z","timestamp":1789982566184,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T00:00:00Z","timestamp":1348963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1038\/nm.2932","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T20:36:51Z","timestamp":1349037411000},"page":"1531-1538","source":"Crossref","is-referenced-by-count":37,"title":["Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract"],"prefix":"10.1038","volume":"18","author":[{"given":"Makoto","family":"Minamiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohide","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,30]]},"reference":[{"key":"BFnm2932_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross, C.A. & Tabrizi, S.J. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10, 83\u201398 (2011).","journal-title":"Lancet Neurol."},{"key":"BFnm2932_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrg1691","volume":"6","author":"JR Gatchel","year":"2005","unstructured":"Gatchel, J.R. & Zoghbi, H.Y. Diseases of unstable repeat expansion: mechanisms and common principles. Nat. Rev. Genet. 6, 743\u2013755 (2005).","journal-title":"Nat. Rev. Genet."},{"key":"BFnm2932_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2010.08.025","volume":"298","author":"J Finsterer","year":"2010","unstructured":"Finsterer, J. Perspectives of Kennedy's disease. J. Neurol. Sci. 298, 1\u201310 (2010).","journal-title":"J. Neurol. Sci."},{"key":"BFnm2932_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.expneurol.2006.01.021","volume":"200","author":"M Katsuno","year":"2006","unstructured":"Katsuno, M. et al. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Exp. Neurol. 200, 8\u201318 (2006).","journal-title":"Exp. Neurol."},{"key":"BFnm2932_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77\u201379 (1991).","journal-title":"Nature"},{"key":"BFnm2932_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1212\/WNL.59.5.770","volume":"59","author":"BJ Schmidt","year":"2002","unstructured":"Schmidt, B.J., Greenberg, C.R., Allingham-Hawkins, D.J. & Spriggs, E.L. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59, 770\u2013772 (2002).","journal-title":"Neurology"},{"key":"BFnm2932_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/112.1.209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue, G. et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112, 209\u2013232 (1989).","journal-title":"Brain"},{"key":"BFnm2932_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/brain\/awh381","volume":"128","author":"H Adachi","year":"2005","unstructured":"Adachi, H. et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 128, 659\u2013670 (2005).","journal-title":"Brain"},{"key":"BFnm2932_CR9","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1471-4159.2009.06302.x","volume":"110","author":"PO Bauer","year":"2009","unstructured":"Bauer, P.O. & Nukina, N. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies. J. Neurochem. 110, 1737\u20131765 (2009).","journal-title":"J. Neurochem."},{"key":"BFnm2932_CR10","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1093\/hmg\/ddm213","volume":"16 Spec No. 2","author":"J Shao","year":"2007","unstructured":"Shao, J. & Diamond, M.I. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum. Mol. Genet. 16 Spec No. 2, R115\u2013R123 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm2932_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno, M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843\u2013854 (2002).","journal-title":"Neuron"},{"key":"BFnm2932_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0896-6273(02)00875-9","volume":"35","author":"K Takeyama","year":"2002","unstructured":"Takeyama, K. et al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35, 855\u2013864 (2002).","journal-title":"Neuron"},{"key":"BFnm2932_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","volume":"67","author":"NB Nedelsky","year":"2010","unstructured":"Nedelsky, N.B. et al. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 67, 936\u2013952 (2010).","journal-title":"Neuron"},{"key":"BFnm2932_CR14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","volume":"13","author":"M Minamiyama","year":"2004","unstructured":"Minamiyama, M. et al. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 13, 1183\u20131192 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm2932_CR15","doi-asserted-by":"publisher","first-page":"12106","DOI":"10.1523\/JNEUROSCI.3032-06.2006","volume":"26","author":"M Katsuno","year":"2006","unstructured":"Katsuno, M. et al. Reversible disruption of dynactin 1\u2013mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. J. Neurosci. 26, 12106\u201312117 (2006).","journal-title":"J. Neurosci."},{"key":"BFnm2932_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/hmg\/ddn310","volume":"18","author":"S Ranganathan","year":"2009","unstructured":"Ranganathan, S. et al. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 18, 27\u201342 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm2932_CR17","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1523\/JNEUROSCI.0388-10.2010","volume":"30","author":"M Katsuno","year":"2010","unstructured":"Katsuno, M. et al. Disrupted transforming growth factor-\u03b2 signaling in spinal and bulbar muscular atrophy. J. Neurosci. 30, 5702\u20135712 (2010).","journal-title":"J. Neurosci."},{"key":"BFnm2932_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan, J.S. et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739\u2013743 (2001).","journal-title":"Nature"},{"key":"BFnm2932_CR19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/nrn1989","volume":"7","author":"R Butler","year":"2006","unstructured":"Butler, R. & Bates, G.P. Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat. Rev. Neurosci. 7, 784\u2013796 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnm2932_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter, R. et al. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9, 1259\u20131271 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm2932_CR21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","volume":"24","author":"K Obrietan","year":"2004","unstructured":"Obrietan, K. & Hoyt, K.R. CRE-mediated transcription is increased in Huntington's disease transgenic mice. J. Neurosci. 24, 791\u2013796 (2004).","journal-title":"J. Neurosci."},{"key":"BFnm2932_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars, K.L. & Rubinsztein, D.C. Transcriptional abnormalities in Huntington disease. Trends Genet. 19, 233\u2013238 (2003).","journal-title":"Trends Genet."},{"key":"BFnm2932_CR23","doi-asserted-by":"publisher","first-page":"e12922","DOI":"10.1371\/journal.pone.0012922","volume":"5","author":"K Mo","year":"2010","unstructured":"Mo, K. et al. Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease\/spinal bulbar muscular atrophy. PLoS ONE 5, e12922 (2010).","journal-title":"PLoS ONE"},{"key":"BFnm2932_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","volume":"6","author":"TW Ho","year":"2010","unstructured":"Ho, T.W., Edvinsson, L. & Goadsby, P.J. CGRP and its receptors provide new insights into migraine pathophysiology. Nat. Rev. Neurol. 6, 573\u2013582 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnm2932_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M Katsuno","year":"2003","unstructured":"Katsuno, M. et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9, 768\u2013773 (2003).","journal-title":"Nat. Med."},{"key":"BFnm2932_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000125243","volume":"50","author":"P Popper","year":"1989","unstructured":"Popper, P. & Micevych, P.E. The effect of castration on calcitonin gene\u2013related peptide in spinal motor neurons. Neuroendocrinology 50, 338\u2013343 (1989).","journal-title":"Neuroendocrinology"},{"key":"BFnm2932_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0306-4522(03)00159-3","volume":"120","author":"W Ma","year":"2003","unstructured":"Ma, W. et al. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience 120, 677\u2013694 (2003).","journal-title":"Neuroscience"},{"key":"BFnm2932_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.tips.2010.06.006","volume":"31","author":"CS Walker","year":"2010","unstructured":"Walker, C.S., Conner, A.C., Poyner, D.R. & Hay, D.L. Regulation of signal transduction by calcitonin gene\u2013related peptide receptors. Trends Pharmacol. Sci. 31, 476\u2013483 (2010).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnm2932_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0163-7258(02)00173-0","volume":"94","author":"PL Durham","year":"2002","unstructured":"Durham, P.L. & Russo, A.F. New insights into the molecular actions of serotonergic antimigraine drugs. Pharmacol. Ther. 94, 77\u201392 (2002).","journal-title":"Pharmacol. Ther."},{"key":"BFnm2932_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/00003088-200140030-00004","volume":"40","author":"SS Jhee","year":"2001","unstructured":"Jhee, S.S., Shiovitz, T., Crawford, A.W. & Cutler, N.R. Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review. Clin. Pharmacokinet. 40, 189\u2013205 (2001).","journal-title":"Clin. Pharmacokinet."},{"key":"BFnm2932_CR31","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1210\/mend.12.7.0135","volume":"12","author":"PL Durham","year":"1998","unstructured":"Durham, P.L. & Russo, A.F. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene\u2013related peptide enhancer. Mol. Endocrinol. 12, 1002\u20131009 (1998).","journal-title":"Mol. Endocrinol."},{"key":"BFnm2932_CR32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nn1717","volume":"9","author":"G Morfini","year":"2006","unstructured":"Morfini, G. et al. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 9, 907\u2013916 (2006).","journal-title":"Nat. Neurosci."},{"key":"BFnm2932_CR33","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1093\/hmg\/ddh268","volume":"13","author":"HG Serra","year":"2004","unstructured":"Serra, H.G. et al. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Hum. Mol. Genet. 13, 2535\u20132543 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm2932_CR34","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/hmg\/ddq018","volume":"19","author":"K Becanovic","year":"2010","unstructured":"Becanovic, K. et al. Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. Hum. Mol. Genet. 19, 1438\u20131452 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm2932_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainres.2007.10.044","volume":"1187","author":"LF Zheng","year":"2008","unstructured":"Zheng, L.F. et al. Calcitonin gene\u2013related peptide dynamics in rat dorsal root ganglia and spinal cord following different sciatic nerve injuries. Brain Res. 1187, 20\u201332 (2008).","journal-title":"Brain Res."},{"key":"BFnm2932_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.nbd.2011.09.011","volume":"45","author":"C Ringer","year":"2012","unstructured":"Ringer, C., Weihe, E. & Schutz, B. Calcitonin gene\u2013related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1\u2013G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 45, 547\u2013554 (2012).","journal-title":"Neurobiol. Dis."},{"key":"BFnm2932_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.nbd.2009.05.011","volume":"35","author":"C Ringer","year":"2009","unstructured":"Ringer, C., Weihe, E. & Schutz, B. Pre-symptomatic alterations in subcellular betaCGRP distribution in motor neurons precede astrogliosis in ALS mice. Neurobiol. Dis. 35, 286\u2013295 (2009).","journal-title":"Neurobiol. Dis."},{"key":"BFnm2932_CR38","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/sj.bjp.0705337","volume":"139","author":"S Di Angelantonio","year":"2003","unstructured":"Di Angelantonio, S., Giniatullin, R., Costa, V., Sokolova, E. & Nistri, A. Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells. Br. J. Pharmacol. 139, 1061\u20131073 (2003).","journal-title":"Br. J. Pharmacol."},{"issue":"suppl. 2","key":"BFnm2932_CR39","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1007\/s10072-007-0757-5","volume":"28","author":"S Benemei","year":"2007","unstructured":"Benemei, S., Nicoletti, P., Capone, J.A. & Geppetti, P. Pain pharmacology in migraine: focus on CGRP and CGRP receptors. Neurol. Sci. 28 (suppl. 2), S89\u2013S93 (2007).","journal-title":"Neurol. Sci."},{"key":"BFnm2932_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1054\/npep.2000.0810","volume":"34","author":"J Disa","year":"2000","unstructured":"Disa, J., Parameswaran, N., Nambi, P. & Aiyar, N. Involvement of cAMP-dependent protein kinase and pertussis toxin\u2013sensitive G-proteins in CGRP mediated JNK activation in human neuroblastoma cell line. Neuropeptides 34, 229\u2013233 (2000).","journal-title":"Neuropeptides"},{"key":"BFnm2932_CR41","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.2174\/138161207780858384","volume":"13","author":"T Borsello","year":"2007","unstructured":"Borsello, T. & Forloni, G. JNK signalling: a possible target to prevent neurodegeneration. Curr. Pharm. Des. 13, 1875\u20131886 (2007).","journal-title":"Curr. Pharm. Des."},{"key":"BFnm2932_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.expneurol.2008.10.008","volume":"215","author":"V Perrin","year":"2009","unstructured":"Perrin, V. et al. Implication of the JNK pathway in a rat model of Huntington's disease. Exp. Neurol. 215, 191\u2013200 (2009).","journal-title":"Exp. Neurol."},{"key":"BFnm2932_CR43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s12031-010-9454-6","volume":"43","author":"S Mehan","year":"2011","unstructured":"Mehan, S., Meena, H., Sharma, D. & Sankhla, R. JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J. Mol. Neurosci. 43, 376\u2013390 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"BFnm2932_CR44","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1523\/JNEUROSCI.4072-08.2009","volume":"29","author":"JE Young","year":"2009","unstructured":"Young, J.E. et al. Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5\/Hrk. J. Neurosci. 29, 1987\u20131997 (2009).","journal-title":"J. Neurosci."},{"key":"BFnm2932_CR45","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/j.1468-2982.1994.1405320.x","volume":"14","author":"L Edvinsson","year":"1994","unstructured":"Edvinsson, L. & Goadsby, P.J. Neuropeptides in migraine and cluster headache. Cephalalgia 14, 320\u2013327 (1994).","journal-title":"Cephalalgia"},{"key":"BFnm2932_CR46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","volume":"9","author":"M Katsuno","year":"2010","unstructured":"Katsuno, M. et al. for the Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 9, 875\u2013884 (2010).","journal-title":"Lancet Neurol."},{"key":"BFnm2932_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","volume":"10","author":"LE Fern\u00e1ndez-Rhodes","year":"2011","unstructured":"Fern\u00e1ndez-Rhodes, L.E. et al. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol. 10, 140\u2013147 (2011).","journal-title":"Lancet Neurol."},{"key":"BFnm2932_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa, H., Yamamura, K. & Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193\u2013199 (1991).","journal-title":"Gene"},{"key":"BFnm2932_CR49","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm1298","volume":"11","author":"M Waza","year":"2005","unstructured":"Waza, M. et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 11, 1088\u20131095 (2005).","journal-title":"Nat. Med."},{"key":"BFnm2932_CR50","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/hh2301.100812","volume":"89","author":"Y Oh-hashi","year":"2001","unstructured":"Oh-hashi, Y. et al. Elevated sympathetic nervous activity in mice deficient in alphaCGRP. Circ. Res. 89, 983\u2013990 (2001).","journal-title":"Circ. Res."},{"key":"BFnm2932_CR51","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1523\/JNEUROSCI.1242-07.2007","volume":"27","author":"H Adachi","year":"2007","unstructured":"Adachi, H. et al. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J. Neurosci. 27, 5115\u20135126 (2007).","journal-title":"J. Neurosci."},{"key":"BFnm2932_CR52","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/hmg\/ddn419","volume":"18","author":"K Tokui","year":"2009","unstructured":"Tokui, K. et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum. Mol. Genet. 18, 898\u2013910 (2009).","journal-title":"Hum. Mol. Genet."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2932.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2932","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2932.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:35:05Z","timestamp":1684449305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,30]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["BFnm2932"],"URL":"https:\/\/doi.org\/10.1038\/nm.2932","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,30]]}}}